Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1964 2
1966 1
1977 1
1978 1
1979 2
1980 1
1981 2
1982 1
1985 2
1987 1
1989 3
1991 1
1992 3
1993 5
1994 3
1995 3
1996 1
1997 2
1998 4
1999 4
2000 7
2001 1
2002 5
2003 2
2005 3
2006 1
2007 1
2008 1
2009 5
2010 5
2011 3
2012 9
2013 9
2014 8
2015 9
2016 12
2017 6
2018 5
2019 7
2020 18
2021 14
2022 16
2023 11
2024 11

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

193 results

Results by year

Filters applied: . Clear all
Page 1
Dapagliflozin treatment is associated with a reduction of epicardial adipose tissue thickness and epicardial glucose uptake in human type 2 diabetes.
Cinti F, Leccisotti L, Sorice GP, Capece U, D'Amario D, Lorusso M, Gugliandolo S, Morciano C, Guarneri A, Guzzardi MA, Mezza T, Capotosti A, Indovina L, Ferraro PM, Iozzo P, Crea F, Giordano A, Giaccari A. Cinti F, et al. Among authors: guarneri a. Cardiovasc Diabetol. 2023 Dec 19;22(1):349. doi: 10.1186/s12933-023-02091-0. Cardiovasc Diabetol. 2023. PMID: 38115004 Free PMC article. Clinical Trial.
Alternative coenzymes for biocatalysis.
Guarneri A, van Berkel WJ, Paul CE. Guarneri A, et al. Curr Opin Biotechnol. 2019 Dec;60:63-71. doi: 10.1016/j.copbio.2019.01.001. Epub 2019 Feb 1. Curr Opin Biotechnol. 2019. PMID: 30711813 Review. No abstract available.
Patient and Context Factors in the Adoption of Active Surveillance for Low-Risk Prostate Cancer.
Ciccone G, De Luca S, Oderda M, Munoz F, Krengli M, Allis S, Baima CG, Barale M, Bartoncini S, Beldì D, Bellei L, Bellissimo AR, Bernardi D, Biamino G, Billia M, Borsa R, Cante D, Castelli E, Cattaneo G, Centrella D, Collura D, Coppola P, Dalmasso E, Di Stasio A, Fasolis G, Fiorio M, Garibaldi E, Girelli G, Griffa D, Guercio S, Migliari R, Molinaro L, Montefiore F, Montefusco G, Moroni M, Muto G, Ponti di Sant'Angelo F, Ruggiero L, Ruo Redda MG, Serao A, Squeo MS, Stancati S, Surleti D, Varvello F, Volpe A, Zaramella S, Zarrelli G, Zitella A, Bollito E, Gontero P, Porpiglia F, Galassi C, Bertetto O; START Collaborative Group. Ciccone G, et al. JAMA Netw Open. 2023 Oct 2;6(10):e2338039. doi: 10.1001/jamanetworkopen.2023.38039. JAMA Netw Open. 2023. PMID: 37847502 Free PMC article.
Bladder cancer under staging: still unavoidable?
Naselli A, Guarneri A. Naselli A, et al. Among authors: guarneri a. Transl Androl Urol. 2019 Dec;8(Suppl 5):S486-S487. doi: 10.21037/tau.2019.09.44. Transl Androl Urol. 2019. PMID: 32042626 Free PMC article. No abstract available.
Infecting Triatomines with Trypanosomes.
Guarneri AA. Guarneri AA. Methods Mol Biol. 2020;2116:69-79. doi: 10.1007/978-1-0716-0294-2_5. Methods Mol Biol. 2020. PMID: 32221914
Non-glycemic Adverse Effects of Insulin.
Guarneri AM, Hoffman RP. Guarneri AM, et al. Curr Diabetes Rev. 2022;18(2):e012821190877. doi: 10.2174/1573399817666210129104420. Curr Diabetes Rev. 2022. PMID: 33511950
193 results